A 61-year-old man with pharyngitis and stomatitis for 2 months was admitted due to difficulty in swallowing solids. Laryngoscopy demonstrated multiple laryngopharyngeal ulcers with exudative laryngopharyngitis (Figure A). He had elevated IgM antibody for herpes simplex virus (HSV). Acyclovir (750 mg daily) was orally administered soon after admission. After 2 days, he had hematemesis and tarry stool. Hemoglobin level decreased to 4.9 g/dL with hemorrhagic shock and required blood transfusion. Urgent upper gastrointestinal endoscopy showed multiple erosions and ulcers with spurting bleeding in the upper esophagus (Figure B). Multiple skipping erosions and round-shaped ulcers were spread 10 cm-wide. Temporal hematemesis is achieved by endoscopic clips to a visible vessel (Figure C). Punched-out ulcers remained but bleeding arrest was reconfirmed by follow-up endoscopy 3 days later. Sixty days post-discharge, endoscopy showed multiple scaring replaced the lesions (Figure D). His symptoms disappeared completely over time, with no recurrence so far. Our report gives a clinical description of exceedingly rare HSV esophageal ulcers accompanying hematemesis in an immunocompetent individual. Though the patient took warfarin and aspirin for old myocardial and middle cerebral infarction, he was not deemed immunocompromised. We propose esophagitis due to HSV should be considered a causative factor for hematemesis even in an immunocompetent host.
Article info
Publication history
Published online: September 29, 2022
Accepted:
September 26,
2022
Received:
September 22,
2022
Footnotes
Conflicts of Interest: The authors disclose no conflicts.
Funding: The authors report no funding.
Ethical Statement: The corresponding author, on behalf of all authors, jointly and severally, certifies that their institution has approved the protocol for any investigation involving humans or animals and that all experimentation was conducted in conformity with ethical and humane principles of research.
Reporting Guidelines: Not applicable.
Identification
Copyright
© 2022 Published by Elsevier, Inc on behalf of the AGA Institute
User license
Creative Commons Attribution (CC BY 4.0) | How you can reuse 
Elsevier's open access license policy
Creative Commons Attribution (CC BY 4.0)
Permitted
- Read, print & download
- Redistribute or republish the final article
- Text & data mine
- Translate the article
- Reuse portions or extracts from the article in other works
- Sell or re-use for commercial purposes
Elsevier's open access license policy
00164-9&id=gr1.jpg){kind=link}